These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31663037)

  • 1. Effect of Concurrent Gonadotropin-Releasing Hormone Agonist Treatment on Dose and Side Effects of Gender-Affirming Hormone Therapy in Adolescent Transgender Patients.
    Jensen RK; Jensen JK; Simons LK; Chen D; Rosoklija I; Finlayson CA
    Transgend Health; 2019; 4(1):300-303. PubMed ID: 31663037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
    van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
    J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
    van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
    Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria.
    Schagen SEE; Lustenhouwer P; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
    J Sex Med; 2018 Sep; 15(9):1357-1363. PubMed ID: 30224022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study.
    Olson-Kennedy J; Chan YM; Garofalo R; Spack N; Chen D; Clark L; Ehrensaft D; Hidalgo M; Tishelman A; Rosenthal S
    JMIR Res Protoc; 2019 Jul; 8(7):e14434. PubMed ID: 31290407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender affirming medical care of transgender youth.
    Salas-Humara C; Sequeira GM; Rossi W; Dhar CP
    Curr Probl Pediatr Adolesc Health Care; 2019 Sep; 49(9):100683. PubMed ID: 31735692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Pressure Dynamics After Pubertal Suppression with Gonadotropin-Releasing Hormone Analogs Followed by Testosterone Treatment in Transgender Male Adolescents: A Pilot Study.
    Perl L; Segev-Becker A; Israeli G; Elkon-Tamir E; Oren A
    LGBT Health; 2020; 7(6):340-344. PubMed ID: 32735503
    [No Abstract]   [Full Text] [Related]  

  • 9. Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria.
    Brik T; Vrouenraets LJJJ; de Vries MC; Hannema SE
    Arch Sex Behav; 2020 Oct; 49(7):2611-2618. PubMed ID: 32152785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
    Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
    JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study.
    Perl L; Elkon-Tamir E; Segev-Becker A; Israeli G; Brener A; Oren A
    J Pediatr Endocrinol Metab; 2021 Jun; 34(6):741-745. PubMed ID: 33823098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
    Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
    J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating the Trans Youth Research Network: A Collaborative Research Endeavor.
    Olson-Kennedy J; Chan YM; Rosenthal S; Hidalgo MA; Chen D; Clark L; Ehrensaft D; Tishelman A; Garofalo R
    Transgend Health; 2019; 4(1):304-312. PubMed ID: 31701011
    [No Abstract]   [Full Text] [Related]  

  • 14. Headache prevalence in transgender and gender diverse youth: A single-center case-control study.
    Hranilovich JA; Millington K
    Headache; 2023 Apr; 63(4):517-522. PubMed ID: 36988085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care for Transgender Young People.
    Krebs D; Harris RM; Steinbaum A; Pilcher S; Guss C; Kremen J; Roberts SA; Baskaran C; Carswell J; Millington K
    Horm Res Paediatr; 2022; 95(5):405-414. PubMed ID: 35272283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review.
    Chew D; Anderson J; Williams K; May T; Pang K
    Pediatrics; 2018 Apr; 141(4):. PubMed ID: 29514975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
    Spanos C; Bretherton I; Zajac JD; Cheung AS
    World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity.
    Ramos GGF; Mengai ACS; Daltro CAT; Cutrim PT; Zlotnik E; Beck APA
    J Endocrinol Invest; 2021 Jun; 44(6):1151-1158. PubMed ID: 33111215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility concerns of the transgender patient.
    Cheng PJ; Pastuszak AW; Myers JB; Goodwin IA; Hotaling JM
    Transl Androl Urol; 2019 Jun; 8(3):209-218. PubMed ID: 31380227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.